Issues surrounding the health economic evaluation of genomic technologies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Issues surrounding the health economic evaluation of genomic technologies
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 14, Issue 15, Pages 1833-1847
Publisher
Future Medicine Ltd
Online
2013-11-16
DOI
10.2217/pgs.13.183
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-world comparative economics of a 12-gene assay for prognosis in stage II colon cancer.
- (2017) Steven R. Alberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- (2013) Uri Ladabaum et al. ANNALS OF INTERNAL MEDICINE
- A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK
- (2013) S Holt et al. BRITISH JOURNAL OF CANCER
- We screen newborns, don’t we?: realizing the promise of public health genomics
- (2013) James P. Evans et al. GENETICS IN MEDICINE
- The Economics of Genomic Medicine
- (2013) W. Gregory Feero et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Are randomized trials obsolete or more important than ever in the genomic era?
- (2013) John PA Ioannidis et al. Genome Medicine
- Die Nutzung von Informationswertanalysen in Entscheidungen über angewandte Forschung
- (2012) W.H. Rogowski et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- A risk–benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomics
- (2012) Preeti S. Bajaj et al. GENETICS IN MEDICINE
- Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies
- (2012) Patricia A. Deverka et al. GENETICS IN MEDICINE
- Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy
- (2012) Gregory F. Guzauskas et al. GENETICS IN MEDICINE
- Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update
- (2012) David L. Veenstra et al. GENETICS IN MEDICINE
- Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research
- (2012) Katrina A.B. Goddard et al. GENETICS IN MEDICINE
- VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT
- (2012) Katherine Payne et al. HEALTH ECONOMICS
- Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities
- (2012) Xi Lin et al. HEARING RESEARCH
- Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
- (2012) S J L Knight et al. LEUKEMIA
- Paying for personalized care: Cancer biomarkers and comparative effectiveness
- (2012) Rahber Thariani et al. Molecular Oncology
- Using companion and coupled diagnostics within strategy to personalize targeted medicines
- (2012) Donald RJ Singer et al. Personalized Medicine
- Can and should value-based pricing be applied to molecular diagnostics?
- (2012) Martina Garau et al. Personalized Medicine
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- Personalized medicine policy challenges: measuring clinical utility at point of care
- (2012) Tibor van Rooij et al. Expert Review of Pharmacoeconomics & Outcomes Research
- A review of economic evaluations of genetic testing services and interventions (2004–2009)
- (2011) Sandjar Djalalov et al. GENETICS IN MEDICINE
- Is there a need for PGxceptionalism?
- (2011) Muin J. Khoury et al. GENETICS IN MEDICINE
- Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer
- (2011) Peter S. Hall et al. JNCI-Journal of the National Cancer Institute
- Pharmacogenetics in psychiatry: translating research into clinical practice
- (2011) A K Malhotra et al. MOLECULAR PSYCHIATRY
- Value for Money? Array Genomic Hybridization for Diagnostic Testing for Genetic Causes of Intellectual Disability
- (2010) Dean A. Regier et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
- (2010) Mercy Mvundura et al. GENETICS IN MEDICINE
- Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
- (2010) Rena Conti et al. MEDICAL DECISION MAKING
- Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing
- (2010) Joshua A. Roth et al. Public Health Genomics
- Personal genomics: information can be harmful
- (2009) D. F. Ransohoff et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Personal utility and genomic information: Look before you leap
- (2009) Scott D Grosse et al. GENETICS IN MEDICINE
- Comparative effectiveness research and genomic medicine: An evolving partnership for 21st century medicine
- (2009) Muin J Khoury et al. GENETICS IN MEDICINE
- Evaluation of risk prediction updates from commercial genome-wide scans
- (2009) Raluca Mihaescu et al. GENETICS IN MEDICINE
- Evaluating the utility of personal genomic information
- (2009) Morris W Foster et al. GENETICS IN MEDICINE
- Fish and chips all round? Regulation of DNA-based genetic diagnostics
- (2009) Katherine Payne HEALTH ECONOMICS
- The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study
- (2009) Wolf H. Rogowski MEDICAL DECISION MAKING
- Challenges of translating genetic tests into clinical and public health practice
- (2009) Wolf H. Rogowski et al. NATURE REVIEWS GENETICS
- Pharmacogenetics in Europe: Barriers and Opportunities
- (2009) D. Gurwitz et al. Public Health Genomics
- Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and Ethics
- (2009) S.D. Grosse et al. Public Health Genomics
- Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
- (2008) Scott D Grosse et al. GENETICS IN MEDICINE
- Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders
- (2008) Jose de Leon NEUROPSYCHOPHARMACOLOGY
- The impact of next-generation sequencing technology on genetics
- (2008) Elaine R. Mardis TRENDS IN GENETICS
- Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key
- (2007) Katherine Payne PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now